标题
Metastatic colorectal cancer: mechanisms and emerging therapeutics
作者
关键词
-
出版物
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 44, Issue 4, Pages 222-236
出版商
Elsevier BV
发表日期
2023-02-23
DOI
10.1016/j.tips.2023.01.003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer
- (2022) Bing Yan et al. BMC GASTROENTEROLOGY
- Immune phenotypic linkage between colorectal cancer and liver metastasis
- (2022) Yedan Liu et al. CANCER CELL
- The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer
- (2022) Kazuhiro Nagao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
- (2022) Carlotta Antoniotti et al. LANCET ONCOLOGY
- Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients
- (2022) Ori Hassin et al. Nature Communications
- Exploring immunotherapy in colorectal cancer
- (2022) Junyong Weng et al. Journal of Hematology & Oncology
- PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
- (2022) Andrea Cercek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells
- (2022) Adrià Cañellas-Socias et al. NATURE
- Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features
- (2021) Pauline A. J. Mendelaar et al. Nature Communications
- Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression
- (2021) Alexandros Lalos et al. Scientific Reports
- FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma
- (2021) Sandra J. Casak et al. CLINICAL CANCER RESEARCH
- Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial
- (2021) Thierry Andre et al. LANCET ONCOLOGY
- Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
- (2021) Salvatore Siena et al. LANCET ONCOLOGY
- Metastasis-Initiating Cells and Ecosystems
- (2021) Joan Massagué et al. Cancer Discovery
- The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
- (2021) Maurice Michel et al. Cancers
- Tissue-specific tregs in cancer metastasis: opportunities for precision immunotherapy
- (2021) Laura A. Huppert et al. Cellular & Molecular Immunology
- Novel therapeutic strategies: targeting epithelial–mesenchymal transition in colorectal cancer
- (2021) Nan Zhang et al. LANCET ONCOLOGY
- Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level
- (2021) Yingcheng Wu et al. Cancer Discovery
- Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives
- (2021) Christopher J. Hanley et al. Oncotarget
- A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
- (2021) Ehsan Razeghian et al. Stem Cell Research & Therapy
- Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis
- (2021) Hossein Sendi et al. CANCER RESEARCH
- First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study
- (2021) Heinz-Josef Lenz et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer
- (2021) Jie Xu et al. Cell Death & Disease
- Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling
- (2021) Beiping Zhong et al. Cell Death & Disease
- The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
- (2021) Hiroki Kobayashi et al. GASTROENTEROLOGY
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer
- (2020) Arianna Fumagalli et al. Cell Stem Cell
- EMT, MET, Plasticity, and Tumor Metastasis
- (2020) Basil Bakir et al. TRENDS IN CELL BIOLOGY
- Myeloid-Derived Suppressor Cells in Colorectal Cancer
- (2020) Izabela Sieminska et al. Frontiers in Immunology
- Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer
- (2020) Dengbo Ji et al. Journal for ImmunoTherapy of Cancer
- Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis
- (2020) Holger Rumpold et al. BMC CANCER
- Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
- (2020) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
- (2020) Thierry André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
- (2020) Erez N. Baruch et al. SCIENCE
- Immunotherapy in colorectal cancer: rationale, challenges and potential
- (2019) Karuna Ganesh et al. Nature Reviews Gastroenterology & Hepatology
- Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
- (2019) Funda Meric-Bernstam et al. LANCET ONCOLOGY
- Efficiency of CAR-T Therapy for Treatment of Solid Tumor in Clinical Trials: A Meta-Analysis
- (2019) Bin Hou et al. DISEASE MARKERS
- VEGF in Signaling and Disease: Beyond Discovery and Development
- (2019) Rajendra S. Apte et al. CELL
- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
- (2019) Jonathan Cooper et al. CANCER CELL
- Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30− Tumors
- (2019) Andreas A. Hombach et al. MOLECULAR THERAPY
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
- (2019) Scott Kopetz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pan-cancer whole-genome analyses of metastatic solid tumours
- (2019) Peter Priestley et al. NATURE
- Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice
- (2018) Yusuf A. Haggag et al. BIOMEDICINE & PHARMACOTHERAPY
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
- (2018) Rona Yaeger et al. CANCER CELL
- EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
- (2018) Nicole M. Aiello et al. DEVELOPMENTAL CELL
- The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
- (2018) Wei-Wei Zhang et al. HUMAN GENE THERAPY
- E-cadherin in contact inhibition and cancer
- (2018) Alisha M. Mendonsa et al. ONCOGENE
- Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
- (2018) Hilla Solomon et al. ONCOGENE
- Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
- (2018) Michael S. Magee et al. Cancer Immunology Research
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
- (2017) Kristen M. Hege et al. Journal for ImmunoTherapy of Cancer
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- (2016) Emeric Limagne et al. CANCER RESEARCH
- Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
- (2016) Andrea Sartore-Bianchi et al. LANCET ONCOLOGY
- Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas
- (2015) S. M. Leto et al. CLINICAL CANCER RESEARCH
- Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
- (2015) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
- (2015) Ryan B. Corcoran et al. JOURNAL OF CLINICAL ONCOLOGY
- TAS-102 for metastatic refractory colorectal cancer
- (2015) Sean Cleghorn LANCET ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fecal microbiota transplantation: in perspective
- (2015) Shaan Gupta et al. Therapeutic Advances in Gastroenterology
- Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer
- (2015) Joke Tommelein et al. Frontiers in Oncology
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study
- (2014) Timothy J Price et al. LANCET ONCOLOGY
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of Systemic Therapy for Colorectal Cancer
- (2009) Rachel Goodwin et al. Clinics in Colon and Rectal Surgery
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started